WayPoint Biomedical Holdings Company Description
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment.
It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection.
The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction.
In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets.
WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
| Country | United States |
| Founded | 2004 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Steven Fox |
Contact Details
Address: 17011 Beach Boulevard Huntington Beach, California 92647 United States | |
| Phone | 714-848-3200 |
Stock Details
| Ticker Symbol | WYPH |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US9467552041 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Steven Fox | Chief Executive Officer |
| Phill Richer | Director of Sales and Marketing |